Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results
Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today.
Reported sales increased 2.3% year-over-year to $21.4 billion.
The company reported net earnings of $5.3 billion, or $2.20 per share, compared to a loss of $491 million, or $0.19 per share, last year. Adjusted EPS increased 12.4% to $2.71.
Earnings beat expectations while revenues came in line with estimates.
For the full year of 2024, the company expects reported sales to range between $88.0-88.4 billion and adjusted EPS to range between $10.57-10.72.
The stock stayed red in premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key highlights from Pfizer’s (PFE) Q1 2025 earnings results
Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP net income decreased 5% to $2.96 billion, or $0.52 per
PYPL Earnings: PayPal reports higher Q1 2025 revenue and profit
PayPal Holdings Inc. (NASDAQ: PYPL) on Tuesday reported a modest increase in revenue for the first quarter of 2025 when the payment service giant's adjusted earnings rose by double digits.
General Motors (GM) Q1 2025 revenue and adj. earnings beat estimates
Auto giant General Motors (NYSE: GM) on Tuesday announced financial results for the first quarter of 2025, reporting an increase in revenue and adjusted profit. The results also topped expectations.
